TABLE 2.
Patient demographics and clinical indicators.
| Variables | Baseline stage (%) | ASP stage (%) | p |
|---|---|---|---|
| Demographics | - | - | - |
| Number of patients | 264 | 212 | - |
| Gender | 0.501 | ||
| Male | 150 (56.82) | 114 (53.77) | - |
| Female | 114 (43.18) | 98 (46.23) | - |
| Age (years) Mean + s.d. | 45.77 ± 16.81 | 51.50 ± 15.91 | 0.01 |
| LOS (days) | 8.33 ± 7.58 | 13.44 ± 11.83 | 0.01 |
| DoT for therapeutic purposes (days) | 4.74 ± 4.58 | 3.96 ± 2.04 | 0.01 |
| Antibiotic consumption (DDD/1000 patient days) | 739.30 | 564.93 | 0.038 |
| Total number of antibiotic prescriptions (percentage of inappropriate antibiotic used therapeutically) | 443 (35) | 442 (26) | 0.006 |
| Total prescriptions administered IV | 396 (89.39) | 372 (84.16) | 0.341 |
| Appropriately prescribed IV antibiotics | 252 (56.90) | 269 (60.80) | 0.302 |
ASP, antibiotic stewardship programmes; s.d., standard deviation, LOS, length of hospital stay; DoT, duration of antibiotic therapy;DDDs, defined daily doses; IV, intravenous.
p values calculated using the chi-square test or t-test where appropriate.